Return On Assets of Mersana Therapeutics, Inc. from 31 Mar 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Mersana Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 31 Mar 2018 to 30 Sep 2025.
  • Mersana Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -69%, a 80% decline year-over-year.
  • Mersana Therapeutics, Inc. annual Return On Assets for 2024 was -40%, a 36% increase from 2023.
  • Mersana Therapeutics, Inc. annual Return On Assets for 2023 was -63%, a 11% increase from 2022.
  • Mersana Therapeutics, Inc. annual Return On Assets for 2022 was -70%, a 4.2% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Mersana Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -69% -31% -80% 01 Jul 2025 30 Sep 2025
Q2 2025 -58% -10% -20% 01 Apr 2025 30 Jun 2025
Q1 2025 -49% +5% +9.5% 01 Jan 2025 31 Mar 2025
Q4 2024 -40% +23% +36% 01 Oct 2024 31 Dec 2024
Q3 2024 -39% +27% +41% 01 Jul 2024 30 Sep 2024
Q2 2024 -48% +20% +29% 01 Apr 2024 30 Jun 2024
Q1 2024 -54% +17% +24% 01 Jan 2024 31 Mar 2024
Q4 2023 -63% +8% +11% 01 Oct 2023 31 Dec 2023
Q3 2023 -65% +15% +19% 01 Jul 2023 30 Sep 2023
Q2 2023 -69% +15% +17% 01 Apr 2023 30 Jun 2023
Q1 2023 -71% +7% +8.8% 01 Jan 2023 31 Mar 2023
Q4 2022 -70% +3% +4.2% 01 Oct 2022 31 Dec 2022
Q3 2022 -81% -20% -34% 01 Jul 2022 30 Sep 2022
Q2 2022 -83% -35% -74% 01 Apr 2022 30 Jun 2022
Q1 2022 -78% -40% -107% 01 Jan 2022 31 Mar 2022
Q4 2021 -74% -37% -102% 01 Oct 2021 31 Dec 2021
Q3 2021 -60% -23% -61% 01 Jul 2021 30 Sep 2021
Q2 2021 -48% -4% -8.6% 01 Apr 2021 30 Jun 2021
Q1 2021 -38% +20% +35% 01 Jan 2021 31 Mar 2021
Q4 2020 -36% -15% -67% 01 Oct 2020 31 Dec 2020
Q3 2020 -38% -9% -33% 01 Jul 2020 30 Sep 2020
Q2 2020 -44% -14% -46% 01 Apr 2020 30 Jun 2020
Q1 2020 -58% -30% -107% 01 Jan 2020 31 Mar 2020
Q4 2019 -22% +43% +66% 01 Oct 2019 31 Dec 2019
Q3 2019 -28% +22% +44% 01 Jul 2019 30 Sep 2019
Q2 2019 -30% +7% +20% 01 Apr 2019 30 Jun 2019
Q1 2019 -28% +8% +23% 01 Jan 2019 31 Mar 2019
Q4 2018 -65% 01 Oct 2018 31 Dec 2018
Q3 2018 -50% 01 Jul 2018 30 Sep 2018
Q2 2018 -37% 01 Apr 2018 30 Jun 2018
Q1 2018 -36% 01 Jan 2018 31 Mar 2018

Mersana Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -40% +23% +36% 01 Jan 2024 31 Dec 2024
2023 -63% +8% +11% 01 Jan 2023 31 Dec 2023
2022 -70% +3% +4.2% 01 Jan 2022 31 Dec 2022
2021 -74% -37% -102% 01 Jan 2021 31 Dec 2021
2020 -36% -15% -67% 01 Jan 2020 31 Dec 2020
2019 -22% +43% +66% 01 Jan 2019 31 Dec 2019
2018 -65% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.